• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Albemarle Corporation

    3/8/24 4:34:02 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    8-A12B 1 form8-a03062024.htm 8-A12B Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
    _________________________________
    FORM 8-A 
     _________________________________
    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
    PURSUANT TO SECTION 12(b) OR (g)
    OF THE SECURITIES EXCHANGE ACT OF 1934
     
    _________________________________
    ALBEMARLE CORPORATION
    (Exact name of Registrant as specified in charter)
    _________________________________
     
    VIRGINIA 54-1692118
    (State of Incorporation or Organization) (I.R.S. Employer Identification No.)

    4250 Congress Street, Suite 900
    Charlotte, North Carolina 28209
    (Address of Principal Executive Offices) (Zip code)
    Securities to be registered pursuant to Section 12(b) of the Act:
     
    Title of Each Class
    to be So Registered
     
    Name of Each Exchange on Which
    Each Class is to be Registered
    Albemarle Corporation Depositary Shares, each Representing a 1/20th Interest in a Share of 7.25% Series A Mandatory Convertible Preferred Stock
     New York Stock Exchange
     
    _________________________________
    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective upon filing pursuant to General Instruction A.(c), please check the following box.  ☒
    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective upon filing pursuant to General Instruction A.(d), please check the following box.  ☐
    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.  ☐

    Securities Act registration statement file number to which this form relates:
    333-269815
    Securities to be registered pursuant to Section 12(g) of the Act:
    None
     
    _________________________________





    Item 1.Description of Registrant’s Securities to be Registered
    The securities to be registered hereby are the Depositary Shares (the “Depositary Shares”), each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock, without par value with an initial liquidation preference of $1,000 per share (the “Mandatory Convertible Preferred Stock”), of Albemarle Corporation (the “Company”). The descriptions of the terms of the Depositary Shares and the underlying Mandatory Convertible Preferred Stock set forth under the headings “Description of Depositary Shares” and “Description of Mandatory Convertible Preferred Stock,” respectively, in the Company’s Prospectus Supplement, dated March 5, 2024, to the Prospectus, dated March 4, 2024, forming a part of the Company’s Registration Statement on Form S-3 (File No. 333-269815), filed under the Securities Act of 1933, as amended, are hereby incorporated herein by reference.
    Item 2. Exhibits.
     
    Exhibit
    Number  Description
    3.1  
    Amended and Restated Articles of Incorporation of Albemarle Corporation, filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (No. 1-12658) filed on August 7, 2018, and incorporated herein by reference.
    3.2  
    Amended and Restated Bylaws of the Registrant effective as of October 23, 2023, filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K (No. 1-12658) filed on October 26, 2023, and incorporated herein by reference.
    3.3  
    Articles of Amendment, filed with the State Corporation Commission of the Commonwealth of Virginia and effective on March 7, 2024, filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on March 8, 2024, and incorporated herein by reference.
    4.1  
    Form of Certificate for the 7.25% Series A Mandatory Convertible Preferred Stock, included as Exhibit A to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on March 8, 2024, and incorporated herein by reference.
    4.2  
    Deposit Agreement, dated as of March 8, 2024, among Albemarle Corporation, Equiniti Trust Company, LLC, as Depositary, and the holders from time to time of the depositary receipts described therein, filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 8, 2024, and incorporated herein by reference.
    4.3  
    Form of Depositary Receipt for the Depositary Shares, filed as Exhibit 4.3 to the Company's Current Report on Form 8-K filed on March 8, 2024, and incorporated herein by reference.







    SIGNATURE
    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.
     
      
    Albemarle Corporation
     
      By:
    /s/ Kristin M. Coleman
    Date: March 8, 2024  Kristin M. Coleman
    Executive Vice President, General Counsel and Corporate Secretary


    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    1/21/2026$205.00Hold → Buy
    Truist
    1/20/2026$200.00Hold → Buy
    HSBC Securities
    1/13/2026$185.00Hold → Buy
    Deutsche Bank
    1/12/2026$200.00Sector Perform → Sector Outperform
    Scotiabank
    1/7/2026$210.00Neutral → Outperform
    Robert W. Baird
    12/16/2025$147.00Underweight → Equal-Weight
    Morgan Stanley
    12/5/2025$185.00Neutral → Buy
    UBS
    12/2/2025$113.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Masters J Kent covered exercise/tax liability with 27,459 shares, decreasing direct ownership by 19% to 118,853 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    1/2/26 4:13:08 PM ET
    $ALB
    Major Chemicals
    Industrials

    Chief Financial Officer Sheorey Neal Ravi covered exercise/tax liability with 854 shares and converted options into 1,953 shares, increasing direct ownership by 10% to 12,210 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/10/25 4:13:38 PM ET
    $ALB
    Major Chemicals
    Industrials

    General Counsel & Sec Krupa Ander C. sold $18,060 worth of shares (172 units at $105.00), decreasing direct ownership by 1% to 11,483 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    10/28/25 4:17:35 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    SEC Filings

    View All

    SEC Form 10-K filed by Albemarle Corporation

    10-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:49:08 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:23:21 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    1/29/26 11:23:22 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Lithium Reclaims Its Role as a Critical Growth Metal as Miners Ramp Up Operations in 2026

    NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium demand is picking up real momentum as electric vehicles and energy storage continue to scale globally. EVs remain the biggest driver, but what's changing the story is how quickly battery storage for power grids, renewables, and data centers is growing. As governments and utilities push for more reliable, low-carbon power, lithium-based batteries are becoming essential infrastructure. Industry forecasts continue to point to lithium demand more than doubling by the end of the decade, with 2026 shaping up as a key inflection year where demand growth clearly outpaces new supply. Active Companies the marke

    1/15/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by Truist with a new price target

    Truist upgraded Albemarle from Hold to Buy and set a new price target of $205.00

    1/21/26 8:25:13 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Albemarle from Hold to Buy and set a new price target of $200.00

    1/20/26 8:06:42 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Albemarle from Hold to Buy and set a new price target of $185.00

    1/13/26 8:40:16 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Fourth Quarter 2025 Earnings Results on Wednesday, February 11, 2026

    CHARLOTTE, N.C., Jan. 13, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its fourth quarter 2025 earnings after the NYSE closes on Wednesday, February 11, 2026. The company will hold a conference call to discuss its fourth quarter 2025 results on Thursday, February 12, at 8 a.m. EST. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.alb

    1/13/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials